A cGAMP-containing hydrogel for prolonged SARS-CoV-2 RBD subunit vaccine exposure induces a broad and potent humoral response
V. Böhnert, E. C. Gale, L. J. Lahey, J. Yan, A. E. Powell, B. S. Ou, J. A. Carozza, L. Li, E. Appel
A cGAMP-containing hydrogel vaccine enhances RBD subunit vaccine efficacy by enabling sustained antigen and adjuvant delivery, resulting in broader and more potent antibody responses.
bioRxiv · Jul 3, 2021 · PreprintBioengineering